Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro

Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro

Bibliographic Details
Main Authors:	Trine Lisberg Toft-Bertelsen, Mads Gravers Jeppesen, Eva Tzortzini, Kai Xue, Karin Giller, Stefan Becker, Amer Mujezinovic, Bo Hjorth Bentzen, Loren B. Andreas, Antonios Kolocouris, Thomas Nitschke Kledal, Mette Marie Rosenkilde
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-12-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-021-02940-2

Similar Items

Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels?
by: Trine L. Toft-Bertelsen, et al.
Published: (2022-08-01)

Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels?
by: Trine L. Toft-Bertelsen, et al.
Published: (2022-09-01)

Molecular Biophysics of Class A G Protein Coupled Receptors–Lipids Interactome at a Glance—Highlights from the A<sub>2A</sub> Adenosine Receptor
by: Efpraxia Tzortzini, et al.
Published: (2023-06-01)

Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1
by: Julius Maximilian Knerr, et al.
Published: (2021-08-01)

Amantadine, new look at the well-known medicine
by: Andrzej Stańczak, et al.
Published: (2022-11-01)

Amantadine variant – aryl conjugates that inhibit multiple M2 mutant – amantadine resistant influenza a viruses
by: Christina Tzitzoglaki, et al.
Published: (2022-12-01)

Amantadine: an antiviral and antiparkinsonian agent
by: J. Staničová, et al.
Published: (2001-09-01)

AMANTADINES: EXPERIENCE OF APPLICATION FOR PARKINSON DISEASE
by: A. A. PILIPOVICH, et al.
Published: (2016-12-01)

Paraneoplastic Chorea Managed with Intravenous Amantadine
by: Nicholas Doher, et al.
Published: (2019-12-01)

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
by: Jack T Nguyen, et al.
Published: (2012-01-01)

Amantadine-induced livedo reticularis - Case report
by: Maria Victória Quaresma, et al.
Published: (2015-10-01)

A modified method for synthesis of amantadine hydrochloride
by: Binh Duong Vu, et al.
Published: (2020-08-01)

Simple and Economical Process for Producing Amantadine Hydrochloride
by: Phuong Dung Phan Thi, et al.
Published: (2022-02-01)

Comprehensive Overview of Homogeneous Gold-Catalyzed Transformations of π-Systems for Application Scientists
by: Ioannis Stylianakis, et al.
Published: (2023-05-01)

Improved Synthesis of the Antitubercular Agent SQ109
by: Marianna Stampolaki, et al.
Published: (2021-12-01)

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
by: Dennis Morrison, et al.
Published: (2007-12-01)

TRPing to the Point of Clarity: Understanding the Function of the Complex TRPV4 Ion Channel
by: Trine L. Toft-Bertelsen, et al.
Published: (2021-01-01)

TRPing on Cell Swelling - TRPV4 Senses It
by: Trine L. Toft-Bertelsen, et al.
Published: (2021-09-01)

Belly dancer syndrome improved by withdrawal of droxidopa and amantadine
by: Mihiro Kaga, et al.
Published: (2023-04-01)

Amantadine Inhibits SARS-CoV-2 In Vitro
by: Klaus Fink, et al.
Published: (2021-03-01)

Myoclonus Secondary to Amantadine: Case Report and Literature Review
by: Jamir Pitton Rissardo, et al.
Published: (2023-07-01)

Amantadine in Treatment of Dysthymia—The Pilot Case Series Study
by: Marek Krzystanek, et al.
Published: (2023-06-01)

Amantadine can induce intra-epithelial deposition in the cornea
by: Asayo Yoshinaka, et al.
Published: (2020-09-01)

Clinical and genetic investigation of amantadine-associated corneal edema
by: Hessen MM, et al.
Published: (2018-08-01)

Amantadine in the treatment of Pathological Gambling: a case report
by: Mauro ePettorruso, et al.
Published: (2012-11-01)

Trial of Amantadine in Anoxic Brain Injury and CNS Lymphoma
by: Kritika Subramanian, et al.
Published: (2020-10-01)

Comparison of LC-MS<sup>3</sup> and LC-MRM Methods for Quantifying Amantadine and Its Application in Therapeutic Amantadine Monitoring in Human Plasma
by: Qiang Sun, et al.
Published: (2022-11-01)

Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
by: Christian Berg, et al.
Published: (2023-02-01)

The Effectiveness of Amantadine in Improving Consciousness in Patients with Acute Brain Injury
by: Alireza Rahat Dahmardeh, et al.
Published: (2023-08-01)

Amantadine-induced corneal edema: A case and literature review
by: Antony Raharja, et al.
Published: (2023-12-01)

Amantadine Toxicity in <i>Apostichopus japonicus</i> Revealed by Proteomics
by: Junqiang Zhao, et al.
Published: (2023-02-01)

In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides
by: Jorge L. Arias-Arias, et al.
Published: (2021-09-01)

Amantadine in parkinson’s disease: modern possibilities of long-term therapy
by: V. V. Poleshchuk, et al.
Published: (2018-05-01)

Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride
by: Mylien T. Hoang, et al.
Published: (2015-09-01)

Amantadine toxic effect and acute psychosis – a case report
by: Dariusz Gruca, et al.
Published: (2023-01-01)

The effect of amantadine on an ion channel protein from Chikungunya virus.
by: Debajit Dey, et al.
Published: (2019-07-01)

Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial.
by: Hideyuki Sawada, et al.
Published: (2010-01-01)

A Case Report of Severe Delirium after Amantadine Withdrawal
by: Franz Marxreiter, et al.
Published: (2017-03-01)

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
by: Steinmann, E, et al.
Published: (2007)

Antiglycoxidative properties of amantadine – a systematic review and comprehensive in vitro study
by: Miłosz Nesterowicz, et al.
Published: (2023-12-01)